Aktis Oncology Welcomes Mary Thistle to Board Amid Strategic Growth Phase Mary Thistle has been appointed to Aktis Oncology's Board of Directors, leveraging her extensive biotech experience as the company aims to enhance its growth in targeted radiopharmaceuticals.

Aktis Oncology Welcomes Mary Thistle to Board Amid Strategic Growth Phase #United_States #Boston #Aktis_Oncology #Mary_Thistle #Biotech_Industry